|Articles|February 1, 2002

New Approaches to the Treatment of Migraine: Clinical and Economic Impact
Volume 8
Issue 3 Suppl

Introduction

Author(s)Lisa K. Mannix, MD

Download PDF: Introduction

Articles in this issue

about 24 years ago

Article

Participating Faculty

about 24 years ago

Article

Migraine: Diagnosis, Management, and New Treatment Options

about 24 years ago

Article

Almotriptan: A Review of Pharmacology, Clinical Efficacy, and Tolerability

about 24 years ago

Article

Economic Comparison of Oral Triptans for Management of Acute Migraine: Implications for Managed Care

about 24 years ago

Article

Health Outcomes Evaluations: Estimating the Impact of Almotriptan in Managed Care Settings

about 24 years ago

Article

Almotriptan Versus Sumatriptan in Migraine Treatment: Direct Medical Costs of Managing Adverse Chest Symptoms

about 24 years ago

Article

Cost Savings in Migraine Associated with Less Chest Pain on New Triptan Therapy

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!

Latest CME

AJMC Supplement

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

2.0 Credits / Pain Management

On-Demand Virtual Symposium

Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care

1.5 Credits / Gynecologic Cancer, Health Equity, Diversity & Inclusion, Oncology, Women's Health

On-Demand Virtual Symposium

Leveraging Managed Care to Optimize Patient Outcomes: Integrating Novel Treatments in Schizophrenia

1.5 Credits / Neurology, Psychiatry

Introduction

Articles in this issue

Newsletter

Related Content

Quality of Life: The Pending Outcome in Idiopathic Pulmonary Fibrosis

Increased Payments to Medicare Advantage Plans for Dually Eligible Beneficiaries

The Health Information Technology Special Issue: Tracking Expansion Across Settings, Technologies, and Stakeholders

Building Trust: Public Priorities for Health Care AI Labeling

Ambient AI Tool Adoption in US Hospitals and Associated Factors

Latest CME

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care

Leveraging Managed Care to Optimize Patient Outcomes: Integrating Novel Treatments in Schizophrenia

Trending on AJMC

FDA to Restrict Ingredients Used in Mass-Marketed Compounded GLP-1s, Crack Down on Misleading Ads

TrumpRx Launch Brings Savings—and Uncertainty

MID Models Reduce Adverse Events, Lower Costs in Oncology: Kenneth Komorny, PharmD, BCPS

Contributor: Reimagining Beneficiary Engagement in Accountable Care Models to Make America Healthy Again

5 Things to Know About the Oral GLP-1 Era